Measuring the Concurrent Validity of the Upper Limb Use Ratio With Accelerometers in an Ecological Situation After Stroke.
Launched by UNIVERSITY HOSPITAL, MONTPELLIER · Jul 13, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how well a special measurement called the "upper limb use ratio" works when tracked with devices called accelerometers in real-life situations after a stroke. Essentially, the study aims to see how accurately these devices can measure how much a person uses their affected arm during everyday activities, especially while they are in occupational therapy.
To participate in this trial, individuals should be at least 18 years old and have weakness in one arm due to a stroke. They need to be involved in activities during their therapy sessions and agree to join the study. However, those with other serious conditions affecting their arms, pregnant or breastfeeding women, and people unable to give consent cannot join. If you participate, you can expect to wear an accelerometer during therapy and help researchers understand better how to measure arm use, which can improve rehabilitation methods for stroke survivors.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subject with hemiparesis following stroke
- • Subject participating in ecological activities during occupational therapy sessions
- • Adult subject aged 18 or over
- • Subject informed of study participation and not objecting to participation
- Exclusion Criteria:
- • Other neurological or musculoskeletal disorders limiting use of upper limbs
- • Pregnant or breast-feeding woman,
- • Failure to obtain consent,
- • Non-affiliation with a social security scheme,
- • Persons under court protection,
- • Person protected by law (under guardianship or curatorship)
- • Participant in another research project with an exclusion period still ongoing.
About University Hospital, Montpellier
The University Hospital of Montpellier is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. Renowned for its commitment to patient-centered care, the hospital collaborates with multidisciplinary teams to explore cutting-edge treatments and therapies across various medical fields. By integrating clinical practice with education and research, the University Hospital of Montpellier aims to enhance health outcomes and contribute to the scientific community's understanding of complex medical conditions. Its robust infrastructure and expertise make it a pivotal player in the landscape of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Montpellier, , France
Lamalou Les Bains, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported